Sfoglia per Autore
Adjuvant Therapy In Surgically Resected Colon Cancer
1992 Rea, Silvio; F., Recchia; L., Belli; M. L., Jaffrainrea; Frati, Luigi
Interferon-beta, retinoids, and tamoxifen in the treatment of metastatic breast cancer: a phase II study
1995 F., Recchia; G., Sica; S., DE FILIPPIS; S., Discepoli; Rea, Silvio; P., Torchio; Frati, Luigi
Combined chemotherapy and differentiation therapy in the treatment of advanced non-small-cell lung cancer
1997 F., Recchia; G., Sica; S. D., Filippis; Rea, Silvio; Frati, Luigi
Advanced carcinoma of the pancreas - Phase II study of combined chemotherapy, beta-interferon, and retinoids
1998 Recchia, F; Sica, G; Casucci, D; Rea, Silvio; Gulino, Alberto; Frati, Luigi
Minimal residual disease in metastatic breast cancer: treatment with IFN-beta, retinoids, and tamoxifen.
1998 Recchia, F; Frati, Luigi; Rea, Silvio; Torchio, P; Sica, G.
Liposomal pegylated doxorubicin and oxaliplatin as salvage chemotherapy in patients with metastatic gastric cancer treated earlier
2010 Recchia, F; Candeloro, G; Guerriero, G; Piazze, J; Desideri, Giovambattista; Necozione, Stefano; Rea, Silvio
Premenopausal hormone-responsive breast cancer with extensive axillary nodes involvement: total estrogen blockade and chemotherapy
2011 Recchia, F; Candeloro, G; Necozione, Stefano; Desideri, Giovambattista; Recchia, Coc; Piazze, J; Rea, Silvio
Long term follow up of a multicenter phase II study of chemo-immunotherapy in the treatment of metastatic colorectal cancer (MCC). J Clin Oncol 29: 2011 (suppl; abstr…)
2011 F., Recchia; G., Candeloro; S., Necozione; P., Lippe; Desideri, Giovambattista; Rea, Silvio
Chemoembolization of unresectable hepatocellular carcinoma: Decreased toxicity with slow-release doxorubicin‑eluting beads compared with lipiodol
2012 Recchia, F; Passalacqua, G; Filauri, P; Doddi, M; Boscarato, P; Candeloro, G; Necozione, Stefano; Desideri, Giovambattista; Rea, Silvio
Triple-negative breast cancer: multipronged approach, single-arm pilot phase II study
2012 Recchia, F; Candeloro, G; Desideri, Giovambattista; Necozione, Stefano; Recchia, Co; Cirulli, V; Rea, Silvio
A multicenter¸open label phase II trial of liposomal doxorubicin (LD) and docetaxel (DX), followed by concurrent chemotherapy and radiation therapy in locally advanced high risk, early breast cancer (HRBC). A multicenter¸open label phase II trial of liposomal doxorubicin (LD) and docetaxel (DX), followed by concurrent chemotherapy and radiation therapy in locally advanced high risk, early breast cancer (HRBC). J Clin Oncol 30: 2012 (ASCO MEETING ABSTRACTS May 30, 2012:e11041 ASCO MEETING ABSTRACTS May 30, 2012:e11041
2012 Recchia, F; Candeloro, G; Cesta, A; Desideri, Giovambattista; Necozione, S; Rea, Silvio
. Extended phase II study of maintenance immunotherapy in advancer Cancer. Proc Am Ass Cancer Res 53:5366, 2012 Abstract #5366
2012 Recchia, F; Candeloro, G; Desideri, Giovambattista; Necozione, S; Rea, Silvio
Vascular endothelial growth factor expression and T-regulatory cells in premenopausal breast cancer
2013 Recchia, F; Candeloro, G; Necozione, Stefano; Desideri, Giovambattista; Cesta, A; Recchia, L; Rea, Silvio
Adjuvant ovarian suppression, high-dose chemotherapy and immunotherapy for premenopausal patients with high-risk breast cancer
2015 Recchia, Francesco; Candeloro, Giampiero; Rosselli, Michele; Bratta, Massimo; Pasta, Vittorio; D'Orazi, Valerio; Fumagalli, Luca A; Rea, Silvio
Primitive sarcoma of the breast: New insight on the proper surgical management
2015 Pasta, Vittorio; Monti, Massimo; Cialini, Michela; Vergine, Massimo; Urciuoli, Paolo; Iacovelli, Annunziata; Rea, Silvio; D'Orazi, Valerio
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile